Send the following on WhatsApp
Continue to Chathttps://www.zonebourse.com/cours/action/PHAXIAM-THERAPEUTICS-S-A-13046812/actualite/ERYTECH-Pharma-annonce-le-recrutement-des-premiers-patients-dans-son-etude-clinique-de-Phase-3-av-27399105/?utm_source=whatsapp&utm_medium=social&utm_campaign=share